Orchard Therapeutics plc (ORTX) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

ProductCollaborationStrimvelis
01M2M3M4M6M7M8M9MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
050M100M150M200M250M300M350M400MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Margin (%)

Gross MarginOperating MarginNet Income Margin
06251K2K2K3K4K4K5KQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Operating Expenses

Research And Development ExpensesSelling General And Administrative Expenses
05M10M15M20M25M30M35M40MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

EBITDA

EBITDA
-60M-28M5M38M70M102M135M168M200MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

EPS

EPSEPS Diluted
048111519222630Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Revenue Variation (%)

Revenue Variation
-100-1275162250338425512600Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
075150225300375450525600Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Revenue YoY Variation (%)

Revenue YoY Variation
-901714326949551K1K2K2KQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
03757501K2K2K2K3K3KQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Price-to-Earning Ratio

P/E Ratio
-3-2-2-2-1-0001Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
050M100M150M200M250M300M350M400MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
02581012151820Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
02581012151820Q3 2022Q4 2022Q1 2023Q2 2023Q3 2023
💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
05K10K15K20K25K30K35K40KQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Free Cash Flow

Cash At End Of Period
012M25M38M50M62M75M88M100MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
05M10M15M20M25M30M35M40MQ3 2022Q4 2022Q1 2023Q2 2023Q3 2023
🏦 Balance Sheet
📈 Key Metrics